Sarah E. Kim
Lawyers
Provides regulatory and compliance advice to investment managers in connection with their ongoing operations and investment activities.
Sarah provides regulatory and compliance advice to investment managers in connection with their ongoing operations and investment activities, including compliance with the Investment Advisers Act and Investment Company Act. She also advises corporations, banks, insurance companies and other financial institutions regarding exemptions under the Investment Company Act and Investment Advisers Act.
She served as a contributing editor for International Comparative Legal Guide: Public Investment Funds 2021, and co-authored the “USA” chapter.
Experience highlights
Recent representations
- Morgan Stanley $3 billion subordinated notes offering
- Texas Instruments $1.5 billion notes offering
- Maravai LifeSciences $1 billion secondary offering
- Morgan Stanley $8.5 billion senior notes offering
- ENN Clean Energy $800 million high-yield notes offering
- Theravance Biopharma $100.5 million follow-on offering
- NatWest Group $750 million Additional Tier 1 capital notes offering
- CARsgen Therapeutics HK$3.1 billion IPO
- ATAI Life Sciences $258.8 million IPO
- Banco Santander Chile CHF150 million notes offering
- NVIDIA $5 billion senior notes offering
- NatWest Group $1.5 billion senior notes offering
- UP Fintech $183.1 million offering of American depositary shares
- Morgan Stanley $3 billion senior notes offering
- Equinix $2.6 billion bond offering, including $1 billion in green bonds
- Automatic Data Processing $1 billion notes offering
Insights
Education
J.D., Harvard Law School
- cum laude
B.A., History, Yale University
Professional history
- Counsel, Davis Polk, 2015-present
- Senior Counsel, PNC Asset Management Group, PNC Bank, 2013-2015
- Regional Legal Counsel, Citi Private Bank, Citibank, Hong Kong Branch, 2002-2013
- Associate, Davis Polk, 1996-2002
Qualifications and Admissions
- State of New York